226 related articles for article (PubMed ID: 11349000)
1. Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation.
Qian HS; Channon K; Neplioueva V; Wang Q; Finer M; Tsui L; George SE; McArthur J
Circ Res; 2001 May; 88(9):911-7. PubMed ID: 11349000
[TBL] [Abstract][Full Text] [Related]
2. Improved vascular gene transfer with a helper-dependent adenoviral vector.
Wen S; Graf S; Massey PG; Dichek DA
Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
[TBL] [Abstract][Full Text] [Related]
3. Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors.
Schneider DB; Sassani AB; Vassalli G; Driscoll RM; Dichek DA
J Vasc Surg; 1999 Mar; 29(3):543-50. PubMed ID: 10069919
[TBL] [Abstract][Full Text] [Related]
4. Infection of endothelium with E1(-)E4(+), but not E1(-)E4(-), adenovirus gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression.
Rafii S; Dias S; Meeus S; Hattori K; Ramachandran R; Feuerback F; Worgall S; Hackett NR; Crystal RG
Circ Res; 2001 May; 88(9):903-10. PubMed ID: 11348999
[TBL] [Abstract][Full Text] [Related]
5. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors.
Mizuguchi H; Kay MA
Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors.
Ramalingam R; Worgall S; Rafii S; Crystal RG
Mol Ther; 2000 Oct; 2(4):381-6. PubMed ID: 11020354
[TBL] [Abstract][Full Text] [Related]
7. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
[TBL] [Abstract][Full Text] [Related]
8. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.
Armentano D; Zabner J; Sacks C; Sookdeo CC; Smith MP; St George JA; Wadsworth SC; Smith AE; Gregory RJ
J Virol; 1997 Mar; 71(3):2408-16. PubMed ID: 9032378
[TBL] [Abstract][Full Text] [Related]
9. p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion.
Tsui LV; Camrud A; Mondesire J; Carlson P; Zayek N; Camrud L; Donahue B; Bauer S; Lin A; Frey D; Rivkin M; Subramanian A; Falotico R; Gyuris J; Schwartz R; McArthur JG
Circ Res; 2001 Aug; 89(4):323-8. PubMed ID: 11509448
[TBL] [Abstract][Full Text] [Related]
10. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T
Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470
[TBL] [Abstract][Full Text] [Related]
11. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
12. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M
J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357
[TBL] [Abstract][Full Text] [Related]
13. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy.
Gao GP; Yang Y; Wilson JM
J Virol; 1996 Dec; 70(12):8934-43. PubMed ID: 8971023
[TBL] [Abstract][Full Text] [Related]
14. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
[TBL] [Abstract][Full Text] [Related]
16. Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function.
Channon KM; Qian HS; Youngblood SA; Olmez E; Shetty GA; Neplioueva V; Blazing MA; George SE
Circ Res; 1998 Jun; 82(12):1253-62. PubMed ID: 9648721
[TBL] [Abstract][Full Text] [Related]
17. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.
Yeh P; Dedieu JF; Orsini C; Vigne E; Denefle P; Perricaudet M
J Virol; 1996 Jan; 70(1):559-65. PubMed ID: 8523570
[TBL] [Abstract][Full Text] [Related]
18. In vivo gene transfer of inducible nitric oxide synthase to carotid arteries from hypercholesterolemic rabbits.
Zanetti M; d'Uscio LV; Kovesdi I; Katusic ZS; O'Brien T
Stroke; 2003 May; 34(5):1293-8. PubMed ID: 12690222
[TBL] [Abstract][Full Text] [Related]
19. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
[TBL] [Abstract][Full Text] [Related]
20. Expression of wild-type and noncleavable Fas ligand by tetracycline-regulated adenoviral vectors to limit intimal hyperplasia in vascular lesions.
Mano T; Luo Z; Suhara T; Smith RC; Esser S; Walsh K
Hum Gene Ther; 2000 Aug; 11(12):1625-35. PubMed ID: 10954897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
